AU2002361028A1 - Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same - Google Patents
Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the sameInfo
- Publication number
- AU2002361028A1 AU2002361028A1 AU2002361028A AU2002361028A AU2002361028A1 AU 2002361028 A1 AU2002361028 A1 AU 2002361028A1 AU 2002361028 A AU2002361028 A AU 2002361028A AU 2002361028 A AU2002361028 A AU 2002361028A AU 2002361028 A1 AU2002361028 A1 AU 2002361028A1
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- prevention
- compounds
- treatment
- agent against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/10—Quaternary compounds
Abstract
Compounds of formula (I), where R1 to R10 have the meanings given in the claims are particularly suitable as anti-hypertensives, for the reduction or prevention of ischaemic induced injury, as medicament for operative intervention in the treatment of ischaemia of the nervous system, stroke, cerebral oedema, shock, disrupted respiration, treatment of snoring, as laxative, as agent against ectoparasites, for prevention of gallstone formation, as antiatherosclerotic, as agent against late diabetic complications, carcinogenic disease states, fibrotic diseases, endothelial dysfunctions, organ hypertrophias and hyperplasias. Said compounds are inhibitors of cellular sodium/proton antiporters, influence serum lipoproteins, and can be used for prophylaxis and regression of atherosclerotic changes.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10163914A DE10163914A1 (en) | 2001-12-22 | 2001-12-22 | Substituted 4-phenyltetrahydroisoquinolinium salts, process for their preparation, their use as medicament, and medicament containing them |
DE10163914.7 | 2001-12-22 | ||
PCT/EP2002/013922 WO2003055880A2 (en) | 2001-12-22 | 2002-12-09 | Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002361028A1 true AU2002361028A1 (en) | 2003-07-15 |
AU2002361028A8 AU2002361028A8 (en) | 2003-07-15 |
Family
ID=7710835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002361028A Abandoned AU2002361028A1 (en) | 2001-12-22 | 2002-12-09 | Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1465870B1 (en) |
JP (1) | JP4495462B2 (en) |
AT (1) | ATE325100T1 (en) |
AU (1) | AU2002361028A1 (en) |
CA (1) | CA2471217A1 (en) |
DE (2) | DE10163914A1 (en) |
MX (1) | MXPA04005796A (en) |
PE (1) | PE20030721A1 (en) |
TW (1) | TW200304823A (en) |
WO (1) | WO2003055880A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10312963A1 (en) * | 2003-03-24 | 2004-10-07 | Aventis Pharma Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
DE102004046492A1 (en) * | 2004-09-23 | 2006-03-30 | Sanofi-Aventis Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
DE102005001411A1 (en) | 2005-01-12 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
DE102005044817A1 (en) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
DE102005044815A1 (en) * | 2005-09-20 | 2007-03-22 | Sanofi-Aventis Deutschland Gmbh | Use of inhibitors of Na + / H + exchanger, subtype 5 (NHE5) for memory improvement |
DE102006012544A1 (en) | 2006-03-18 | 2007-09-27 | Sanofi-Aventis | Substituted 1-amino-4-phenyl-dihydroisoquinolines, process for their preparation, their use as medicament, and medicament containing them |
KR101766619B1 (en) * | 2008-12-31 | 2017-08-08 | 알데릭스, 인코포레이티드 | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
CN106536502B (en) * | 2014-07-25 | 2019-03-05 | 大正制药株式会社 | The phenyl tetrahydro isoquinoline compound being substituted by heteroaryl |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3666763A (en) * | 1970-01-06 | 1972-05-30 | Hoffmann La Roche | 4-phenyl isoquinolines and process for preparing same |
DE4344550A1 (en) * | 1993-12-24 | 1995-06-29 | Hoechst Ag | Substituted 1-oxo-1,2-dihydro-isoquinolinoyl and 1,1-dioxo-2H-1,2-benzothiazinoylguanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them |
DE19951702A1 (en) * | 1999-10-27 | 2001-05-03 | Aventis Pharma Gmbh | Use of 2-amino-3,4-dihydroquinazolines for the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions |
DE10019062A1 (en) * | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia |
-
2001
- 2001-12-22 DE DE10163914A patent/DE10163914A1/en not_active Withdrawn
-
2002
- 2002-12-02 PE PE2002001158A patent/PE20030721A1/en not_active Application Discontinuation
- 2002-12-09 JP JP2003556410A patent/JP4495462B2/en not_active Expired - Fee Related
- 2002-12-09 DE DE50206706T patent/DE50206706D1/en not_active Expired - Lifetime
- 2002-12-09 WO PCT/EP2002/013922 patent/WO2003055880A2/en active IP Right Grant
- 2002-12-09 AT AT02795126T patent/ATE325100T1/en not_active IP Right Cessation
- 2002-12-09 CA CA002471217A patent/CA2471217A1/en not_active Abandoned
- 2002-12-09 MX MXPA04005796A patent/MXPA04005796A/en unknown
- 2002-12-09 EP EP02795126A patent/EP1465870B1/en not_active Expired - Lifetime
- 2002-12-09 AU AU2002361028A patent/AU2002361028A1/en not_active Abandoned
- 2002-12-19 TW TW091136599A patent/TW200304823A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003055880A2 (en) | 2003-07-10 |
DE10163914A1 (en) | 2003-07-03 |
JP2005524616A (en) | 2005-08-18 |
TW200304823A (en) | 2003-10-16 |
EP1465870A2 (en) | 2004-10-13 |
ATE325100T1 (en) | 2006-06-15 |
WO2003055880A3 (en) | 2003-11-06 |
MXPA04005796A (en) | 2004-09-10 |
AU2002361028A8 (en) | 2003-07-15 |
PE20030721A1 (en) | 2003-10-03 |
JP4495462B2 (en) | 2010-07-07 |
CA2471217A1 (en) | 2003-07-10 |
EP1465870B1 (en) | 2006-05-03 |
DE50206706D1 (en) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04100A1 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof , the use thereof as medicaments, in addition to a medicament containing same | |
NL300933I2 (en) | Letermovir | |
NO20055680L (en) | Hexahydropyridoisoquinolines as DPP-IV inhibitors | |
NO20065079L (en) | Materials and methods for the treatment of coagulation disorders | |
WO2006067165A3 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
MY145823A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity | |
EP1251126A3 (en) | Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation | |
AU2003258621A1 (en) | Novel purine derivatives, production and use thereof as medicaments | |
BR0209957A (en) | Compound, process for preparing a compound, pharmaceutical composition comprising a compound, use of such compound and process for the treatment and prophylaxis of arthritis, diabetes, eating disorders and obesity | |
CY1109191T1 (en) | A NEW USE OF DIFFERIPRON | |
UA82980C2 (en) | Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis | |
CA2534428A1 (en) | Melanin concentrating hormone receptor antagonists | |
AU2002361028A1 (en) | Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same | |
IL156467A0 (en) | Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same | |
ATE429916T1 (en) | USE OF SULFONAMIDE DERIVATIVES IN TREATING OBESITY OR FOR REDUCING FOOD CONSUMPTION | |
NO20022801L (en) | Substituted norbornylamino derivatives, processes for their preparation, their use as a medicament or diagnostic as well as drugs containing these | |
WO2004087700A8 (en) | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain | |
MX2022011179A (en) | Medical use of daridorexant. | |
WO2001070737A3 (en) | Therapeutic heterocyclic compounds for the treatment of asthma and allergy and use thereof | |
WO2005011602A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease | |
WO2002098843A3 (en) | Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors | |
WO2007117272A3 (en) | Methods for treatment of hemorrhagic shock and related disorders | |
WO2002000611A3 (en) | Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists | |
BR0011049A (en) | Substituted phenylcyclohexanocarboxamides and their use as adenosine absorption inhibitors | |
MY176510A (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl]benz-amide, its use as a medicament, and pharmaceutical preparations comprising it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |